Enric Mas’ mind is a spinning centrifuge. After arriving at the Lakua hotel at 11pm the day before yesterday, he wandered from 9.30am on the first rest day of the Vuelta through the makeshift paddock that Movistar, Jumbo, Israel, UAE and Quick Step formed on Tarragona street of Victoria .
For the time being, it is dominated by the Jumbo, one of the first risers that started yesterday. Gesink, the first to leave, continues with a smile as the first leader of the race. In the second stage he picked up Teunissen’s jersey and Affini brought it to Spain.
Those in yellow were walking down the street as the Israeli group left the hotel with a prominent figure. Chris Froome took up the claim of the few fans waiting outside. A few minutes earlier, Woods said goodbye to the rest of the members. The Canadian took off in the third stage due to a “minor concussion” of which there were still marks on his face. Evenepoel emerged from the back room, one of the few that seems able to break the pack on the climb to Herrara. Like the rest of his team, he covered 44 kilometers around Zurbano on the time trial bike in training for next Tuesday’s session in Alicante.
Also Movistar. “We’re not going to recognize the ending because we’ve already seen it,” said Patxi Vila, one of the directors. Yesterday seven riders of the Spanish team started training. One was missing. The one that arouses the most expectations and for which twenty fans waited around his bike. But Alejandro Valverde decided not to train yesterday. Perhaps still with the fear in the body after the two nervous stages in line in the Netherlands on which he criticized the layout. Vitoria starts today for the twentieth time (1:40) of the Spanish round. The 152.5 kilometer stage ends in Laguardia.
Source: La Verdad
I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.
